title: Suppression of morphine-induced conditioned place preference by l-12-chloroscoulerine, a novel dopamine receptor ligand.
abstract: The effect of l-12-chloroscoulerine (l-CSL), a novel ligand with dual dopamine D1 receptor agonistic and D2 receptor antagonistic actions, on the development of morphine-induced conditioned place preference (CPP) was investigated in mice. Morphine (10 mg/kg)-induced place preference was dose dependently suppressed by coadministration of l-CSL (5, 10 and 20 mg/kg), which induced neither place preference nor place aversion when administered alone at a dose of 20 mg/kg. The D1 receptor antagonist SCH23390 (0.1 mg/kg) suppressed, whereas the D2 receptor agonist (+/-)-2-(N-phenylethyl-N-propyl)-amino-5-hydroxytetralin (PPHT) (0.5 mg/kg) had no influence on the development of morphine-induced place preference. However, SCH23390 (0.1 mg/kg) did not affect, whereas PPHT (0.5 mg/kg) reversed the suppressive effect of l-CSL on the development of morphine-induced place preference. These results indicate that l-CSL suppresses the development of place preference of morphine by blocking D2 receptors.
authors.affiliation: 2nd Department of Pharmacology, Shanghai Institute of Materia Medica, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai 200031, China.
authors.forename: Zhong-Hua
authors.initials: ZH
authors.lastname: Liu
authors.forename: Wen-Qiao
authors.initials: WQ
authors.lastname: Jin
authors.forename: Hong-Ping
authors.initials: HP
authors.lastname: Zhang
authors.forename: Xin-Jian
authors.initials: XJ
authors.lastname: Chen
authors.forename: Guo-Zhang
authors.initials: GZ
authors.lastname: Jin
mesh_terms: D000818:Animals; D001552:Benzazepines / Q000494:pharmacology; D001600:Berberine Alkaloids / Q000494:pharmacology*; D003216:Conditioning, Operant / Q000187:drug effects*; D018492:Dopamine Antagonists / Q000494:pharmacology*; D065127:Dopamine D2 Receptor Antagonists; D008024:Ligands; D008297:Male; D051379:Mice; D009020:Morphine / Q000037:antagonists & inhibitors* / Q000494:pharmacology*; D009292:Narcotic Antagonists; D009294:Narcotics / Q000494:pharmacology*; D011954:Receptors, Dopamine / Q000187:drug effects*; D017447:Receptors, Dopamine D1 / Q000037:antagonists & inhibitors
chemical_list: C099468:12-chloroscoulerine; D001552:Benzazepines; D001600:Berberine Alkaloids; D018492:Dopamine Antagonists; D065127:Dopamine D2 Receptor Antagonists; D008024:Ligands; D009292:Narcotic Antagonists; D009294:Narcotics; D011954:Receptors, Dopamine; D017447:Receptors, Dopamine D1; D009020:Morphine